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Objective: Human papillomavirus (HPV) infection is a prerequisite of developing cervical cancer,
approximately half of which are associated with HPV type 16. There are reports that HPV can disturb the
expression pattern of host miRNAs, but its mechanism is not well understood.
Materials and Methods: In this study, we scanned 11 tumorigenesis related miRNAs in Hela cells that
were overexpressed with HPV type 16 E6 protein.
Results: We found the expression of miR-21 was upregulated by HPV type 16 E6 protein and meanwhile,
the expression of miR-27a and miR-218 was downregulated. Furthermore, we identiﬁed that miR-21
overexpression could promote Hela and U2OS cells proliferation by targeting phosphatase-tensin
homolog (PTEN), the result of which can be rescued by miR-21 inhibitor. In addition, E6 overexpression
could also promote Hela cell migration and invasion.
Conclusion: Our results indicate that HPV infection and subsequent transformation take place through
complex regulatory patterns of gene expression in the host cells, part of which are regulated by the E6
protein.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Human papillomavirus (HPV) infection is the major cause of
human cervical cancer and persistent infection by one of ~15 ge-
notypes of carcinogenic HPV causes in almost all cases [1]. Themost
prevalent HPV type found in cervical cancer is HPV 16, which en-
codes three oncoproteins: E5, E6, and E7. The E6 and E7 oncopro-
teins can bind to and stimulate the degradation of the tumor
suppressors p53 [2,3] and pRb [4], which are essential for cell cycle
control.
MicroRNAs (miRNAs) are short noncoding RNAs which modu-
late gene expression by binding to complementary segments pre-
sent in the 30UTR of the mRNAs of protein coding genes. miRNAs
play very important roles in maintaining normal human body
physiology conditions, and abnormalmiRNA expressions have been
found related to many human diseases, spanning from psychiatric
disorders [5] to malignant cancers [6,7]. Moreover, they play as and Gynecology, The First
n 150001, Heilongjiang, Peo-
Zheng).
bstetrics & Gynecology. Publishedmajor role in regulating host gene expression in virus infected cells
and cancers caused by virus infection [8e11].
There are no reports that HPV can express its own miRNA,
however, it has been conﬁrmed that HPV infection can disturb host
miRNA expression and is related to tumorigenesis. Downregulation
of human miR-218 in cervical cancer cells was speciﬁcally
addressed to the HPV 16 E6 oncogene [12], but a wide range
interfered miRNAs expression pattern by E6 protein need to be
unveiled. Here we scanned the expression of several tumorigenesis
related miRNAs when HPV E6 protein was overexpressed. Finally,
we found the expression of miR-218 andmiR-27a can be reduced by
E6, and miR-21 was upregulated. This research gives a clue to
explain the mechanism of tumorigenesis induced by HPV infection.Materials and methods
Cell culture
Hela and U2OS cells were cultured in Dulbecco's Modiﬁed Eagle
Medium containing 10% fetal bovine serum (Hyclone, Logan, UT,
USA), 100 IU/mL penicillin, and 10 mg/mL streptomycin. All cells
were maintained at 37C under an atmosphere of 5% CO2.by Elsevier Taiwan LLC. All rights reserved.
W. Ben et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 364e370 365miRNA real-time reverse transcription quantitative polymerase
chain reaction
Reverse transcription quantitative polymerase chain reaction
(RT-qPCR) analysis was used to determine the relative expression
level of candidate miRNAs. Total RNA was extracted from tissues
and cells, using Trizol (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer's instructions. The expression level of miRNAs
was detected by TaqManmiRNA RT-Real Time PCR. Single-stranded
cDNA was synthesized by using TaqMan MicroRNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA, USA) and then
ampliﬁed by using TaqMan Universal PCR Master Mix (Applied
Biosystems) together with miRNA-speciﬁc TaqMan MGB probes
(Applied Biosystems). The U6 snRNA was used for normalization.
Each sample in each group was measured in triplicate and the
experiment was repeated at least three times for the detection of
miRNAs.
Plasmids transfection
HPV16 E6 full length coding regionwas ampliﬁed by RT-PCR and
cloned into pcDNA3.1 vector between the recognition sequence for
Hind III and Xho I. E6 expression vector was transfected into cells by
the lipofectamine 2000 (Invitrogen) essentially as described by the
manufacturer's instruction, pcDNA3.1 vector used as control.Figure 1. Conﬁrmation of the expression of HPV type 16 E6 protein and scanning the expres
vector transfected groups 24 hours and 48 hours after transfection; (B) 11 candidate host
different samples and helps normalize for experimental error. *p < 0.05. HPV ¼ human papWestern blotting
Protein extracts were boiled in SDS/b-mercaptoethanol sample
buffer, and 30 mg samples were loaded into each lane of 8% poly-
acrylamide gels. The proteins were separated by electrophoresis and
then the gels were blotted onto polyvinylidene ﬂuoride (PVDF)
membranes (AmershamPharmaciaBiotech, St.Albans,Hertfordshire,
UK) by electrophoretic transfer. The membrane was incubated with
mouse antiE6 monoclonal antibody (Abcam, Cambridge, MA, USA),
rabbit antiPTENmonoclonal antibody, (Abcam) ormouse antib-actin
monoclonal antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA,
USA) for 1 hour at 37C. The speciﬁc protein antibody complex was
detected by using horseradish peroxidase conjugated rabbit anti-
mouse or goat antirabbit immunoglobulin G. Detection by the
chemiluminescence reaction was carried using the ECL kit (Pierce,
Appleton, WI, USA). The b-actin signal was used as a loading control.
Cell proliferation assay
Hela andU2OS cells were seeded in 96-well plates at lowdensity
(5103) in dulbecco modiﬁed eagle medium (DMEM) culture and
allowed to attach overnight. The cells were then transfectedwith E6
expression vector, with pcDNA3.1 as the control. Twentymicroliters
methyl thiazolyl tetrazolium (MTT) (3-[4, 5-dimethylthiazol-2-yl]
-2, 5-diphenyltetrazolium bromide) (5 mg/mL; Sigma-Aldrich, St.sion of 11 host miRNAs in Hela cells: (A) E6 protein was only detected in E6 expression
miRNAs were detected by RT-qPCR. U6 snRNA serves as an internal reference among
illomavirus; RT-qPCR ¼ reverse transcription quantitative polymerase chain reaction.
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fection, and the cells were incubated further for 4 hours. The
absorbance was recorded at A490 nm with a 96-well plate reader
after the dimethyl sulfoxide (DMSO) addition.
Cell migration and invasion assays
Hela cells were transfected with the pcDNA3.1, pcDNA3.1-E6,
miR-21inhibitorwithpcDNA3.1-E6, or scramblemiRNAcontrolwith
pcDNA3.1-E6. After 48 hours of transfection, the transfected cells
were harvested and subjected to the following assays. During the
formigration assays, the transfected cells (0.5  106 cells/mL) were
seeded in the top of an 8.0-mm-pore membrane chamber (Corning
CostarCorp., Cambridge, MA, USA). Following a 12-hour incubation
period, cells that passed through the membrane and were attached
to the bottom of it were ﬁxed and stained with hematoxylin and
eosin (Sigma-Aldrich). Cellswere scraped and removed from the top
of chamber.Membranesweremounted on cover slides, and the cells
werecounted. Cellmigrationwasquantiﬁedbycounting theamount
of cells passing through the pores from ﬁve different ﬁelds per
sample at 100 selected in a random manner. Cell invasion assays
were carried out usingmodiﬁed Boyden chambers in 24-well tissue
culture plates at 1 105 cells per well (BD Biosciences, San Jose, CA,
USA). All experiments were performed in duplicate.
Stable cell line establishment
Stable cell lines expressing Flag-E6 were generated by trans-
fection of Hela cells in six-well plates with 2 mg of the plasmid usingFigure 2. Conﬁrmation of the expression of HPV type 16 E6 protein and scanning the expres
vector transfected groups 24 hours and 48 hours after transfection; (B) 11 candidate host
different samples and helps normalize for experimental error. *p < 0.05. HPV ¼ human palipofectamin-2000 (Invitrogen) according to the manufacturer's
protocol. Selection for the plasmid was applied using 0.5 mg/mL of
puromycin (Amresco, Solon, OH, USA), beginning 48 hours after
transfection. The puromycin-resistant cell population was tested
for expression of Flag-E6 by immunoblotting with antiFlag anti-
body (Abmart, Shanghai, China).
Statistical analysis
MiRNAs expression data were analyzed using SPSS version 16
(SPSS Inc., Chicago, IL, USA), paired t test was used and p < 0.05 was
considered statistical signiﬁcant.
Results
Conﬁrmation of the overexpression of HPV16 E6 protein
As two time points, 24 hours and 48 hours after plasmid
transfection, Hela and U2OS cells were collected to detect the
expression of HPV16 E6 protein. As shown in Figures 1A and 2A, E6
protein was overexpressed and was not detected in controls of
these two cell lines.
Detection of the expression pattern of 11 tumorigenesis associated
miRNAs
We detected 11 selected miRNAs (miR-15a, miR-15b, miR-16,
miR-21, miR-146a, miR-218, miR-125a, miR-125b, miR-34a, miR-
27a, and miR-27b), the expression of which were disturbed aftersion of 11 host miRNAs in U2OS cells: (A) E6 protein was only detected in E6 expression
miRNAs were detected by RT-qPCR. U6 snRNA serves as an internal reference among
pillomavirus; RT-qPCR ¼ reverse transcription quantitative polymerase chain reaction.
Table 1
Fold change of miR-21, miR-218, and miR-27a by HPV16 E6 protein.
miRNA Fold change
Hela (24 h) Hela (48 h) U2OS (24 h) U2OS (48 h)
miR-21 0.47 1.34 0.38 1.63
miR-218 0.18 0.42 0.56 0.77
miR-27a 0.36 0.88 0.65 1.78
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lations between their disturbance and E6 protein. From the results
of RT-qPCR, we found the expression of miR-21 was upregulated,
miR-218 and miR-27a were declined, especially 48 hours after E6
expression vector transfection (Table 1).
To further conﬁrm the results that E6 overexpression can
disturb miRNAs expression, we established Hela cells that consis-
tently express E6. When the expression of E6 was knocked down by
siRNA, the miR-21 was downregulated and miR-218 was overex-
pressed (Figure 3). These results indicated that the disturbed miR-
21 and miR-218 expression was generated by E6.
E6 overexpression repressed phosphatase-tensin homolog (PTEN)
expression by upregulating miR-21
MiR-21 is identiﬁed as an oncogene which contributes to
carcinogenesis in many kinds of cancers. To explore whether the
upregulated miR-21, caused by E6 overexpression, can repress its
target genes, the expression of PTEN was detected [15,16]. As
shown in Figures 4A and 4B, the expression of PTEN was signiﬁ-
cantly repressed by E6 and the repressed PTEN can be rescued by
miR-21 inhibitor in Hela cells. The results indicated that miR-21Figure 3. Knockdown the expression of HPV E6 protein and detection of the miR-21, miR-
transfected with three E6 speciﬁc siRNAs and 48 hours after transfection, E6 expression wa
detected by RT-qPCR. Results were analyzed by Student t test, p < 0.05 was considered st
quantitative polymerase chain reaction.upregulation, which is caused by E6 overexpression, is the main
factor that repressed PTEN expression. AKT is an important
downstreammultifunctional molecule that is closely related to cell
proliferation and survival. We detected the phosphorylated AKT in
the E6 overexpressed Hela cells. As shown in Figure 4C, the amount
of PeS473 AKT was upregulated by E6 and partially downregulated
by miR-21 inhibitor.
E6 can promote Hela cell proliferation, migration, and invasion
PTEN is a tumor suppressor gene that is frequently mutated in
human tumors. During tumor development, mutations and de-
letions of PTEN occur which inactivates its enzymatic activity
leading to increased cell proliferation and reduced cell death. We
detected the effect of E6 protein on cell proliferation. As shown in
Figure 4D in Hela cells, the cell proliferation can be promoted by E6
overexpression and the result can be rescued by miR-21 inhibitor.
As miR-21 was identiﬁed as an oncomir and overexpression of
miR-21 can promote migration and invasion of cancer cells [12], we
detected the Hela cell migration and invasion ability after E6
expression vector transfection. As shown in Figures 5A and 5B,
when E6 is overexpressed in Hela cells, cell migration and invasion
were upregulated signiﬁcantly. When miR-21 inhibitor was
cotransfected with E6 expression vector, Hela cell migration ability
was repressed signiﬁcantly.
Discussion
Recently, reports that disturbed expression of several tumori-
genesis associated microRNAs is related to HPV infection by
different groups, but the results were not consistent [12,13] (miR-27a, and miR-218 expression: (A) Hela cells that stable express HPV E6 protein were
s detected by Western blots; (B) the expression of miR-21, miR-27a, and miR-218 was
atistically signiﬁcant. HPV ¼ human papillomavirus; RT-qPCR ¼ reverse transcription
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miRNAs expression contributes to HPV-induced tumors.
In this study, we scanned 11 tumorigenesis associated miRNAs
in Hela and U2OS cells that were overexpressed with E6 protein.
We found three miRNAs (miR-21, miR-218, and miR-27a) that were
signiﬁcantly interfered by HPV16 E6 protein. MiR-218 is an
important tumor suppressor and its suppression was reported not
only in cervical cancer tissues, but also in gastric cancer [17], lung
cancer [18], head and neck cancer [19], and so on. Martinez et al
[12] identiﬁed that HPV16 suppress host cell miR-218 expression by
E6 protein, thus our research above conﬁrmed that phenomenon.Figure 4. HPV type E6 protein can promote cell proliferation by upregulating miR-21 expres
(B) E6 protein overexpression can repress PTEN mRNA level in Hela and U2OS cells by upregu
AKT in the different treated groups of Hela cell lysates, and (D) E6 protein overexpression
papillomavirus; PTEN ¼ phosphatase-tensin homolog.MiR-21 is considered by most scientists as an oncogenic miRNA
and its overexpressionwas shown inmost cancer types analyzed so
far [20]. It is also conﬁrmed that miR-21 is overexpressed in HPV
induced cervical cancer, but the mechanism is not well understood
[21]. Our research indicates that HPV16 E6 protein overexpression
can lead to upregulated pri-miR-21 expression and promote Hela
and U2OS cells proliferation by repressing PTEN expression, which
gives a clue to explaining the mechanism of HPV induced miR-21
overexpression.
The oncogenic role of miR-27a is conﬁrmed by several experi-
mental studies. MiR-27a is signiﬁcantly upregulated in renal cellsion: (A) E6 protein overexpression repressed PTEN expression in Hela and U2OS cells;
lating miR-21expression; (C) Western blot was used to detect the S473 phosphorylated
can promote Hela cells proliferation by upregulating miR-21expression. HPV ¼ human
Figure 5. HPV E6 protein promotes Hela cell migration and invasion partially by upregulating miR-21. Hela cells transfected with the pcDNA3.1, pcDNA3.1-E6, miR-21 inhibitor plus
pcDNA3.1-E6 or scramble miRNA control with pcDNA3.1-E6 respectively. The transfected cells were harvested and subjected to the following assays, 48 hours after transfection: (A)
for migration assays, the transfected cells (0.5  106 cells/mL) were seeded in the top of an 8.0-mm-pore membrane chamber (Corning Costar Corp., Cambridge, MA, USA). Following
a 12-hour incubation period, cells that passed through the membrane to attach to the bottom of the membrane were ﬁxed and stained with hematoxylin and eosin (Sigma-Aldrich,
St. Louis, MO, USA). Cells were scraped and removed from the top of chamber. Membranes were mounted on cover slides, and cells were counted. The cell migration was quantiﬁed
by counting the amount of cells passing through the pores from ﬁve different ﬁelds per sample at 100selected in a random manner; (B) cell invasion assays were carried out using
modiﬁed Boyden chambers in 24-well tissue culture plates at 1  105 cells per well (BD Biosciences, San Jose, CA, USA). All experiments were performed in duplicate.
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and breast cancer [25]. Downregulation of miR-27a also caused a
decrease in Bcl-2 expression and increase in the Bax expression,
thereby leading the cancerous cells towards apoptosis [26]. In this
study, miR-27a was downregulated by HPV E6 protein, which is
contrary to the carcinogenesis function of E6. E6 is a multiple
function molecule and may regulate the expressions of transcrip-
tion factors of miR-27a such as RUNX2 [27]. In addition, “miRNA
sponge” is also a potential mechanism that E6 reduce the quantity
of miR-27a in cells [28].
E6 is known for promoting the degradation of the tumor sup-
pressor p53 and activating telomerase expression and activity. E6
also plays a key role in the deregulation of innate immunity by
interfering with the expression of toll-like receptors. Specifically,
toll-like receptor 9 transcription is inhibited in cells expressing
HPV16 E6 and E7 [3]. In this study, we found that E6 overexpression
can upregulate miR-21 expression which have been conﬁrmed
suppressing type I IFN production by targeting myeloid differenti-
ation factor 88 (MyD88) and interleukin-1 receptor-associatedkinase 1 (IRAK1). Therefore, we can infer that disturbed miRNAs
expression may also play a crucial role in the HPV immune evasion
progress.
In the present study, we found HPV16 E6 protein can reduce the
expression of miR-218 and miR-27a and upregulate the expression
of miR-21. This is the ﬁrst report regarding E6 protein function as a
host miRNA modulator and gives an important clue to explain the
mechanism of HPV induced carcinogenesis.
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